RVMD
NASDAQ · Biotechnology
Revolution Medicines Inc
$178.17
+8.40 (+4.95%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+121.27%
1Y
+375.37%
YTD
+125.47%
Open$170.94
Previous Close$169.77
Day High$184.39
Day Low$168.19
52W High$166.50
52W Low$34.00
Volume—
Avg Volume2.63M
Market Cap34.65B
P/E Ratio—
EPS$-4.80
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$94.85
Above
SMA 200
$58.23
Above
RSI (14)
62.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
27 analysts
Price Target
-36.0% upside
Current
$178.17
$178.17
Target
$114.11
$114.11
$80.83
$114.11 avg
$120.13
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 7.27B | 6.60B | 6.07B |
| Net Income | 320.45M | 295.32M | 319.17M |
| Profit Margin | 4.4% | 4.5% | 5.3% |
| EBITDA | 413.26M | 366.06M | 402.03M |
| Free Cash Flow | 328.07M | 289.36M | 393.55M |
| Rev Growth | +0.4% | +7.5% | +13.8% |
| Debt/Equity | 0.86 | 0.80 | 0.86 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $243.14 | +3.51% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $352.82 | +0.40% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $123.84 | -1.05% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $480.18 | +1.05% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $620.14 | -0.53% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $293.17 | -0.30% | 64.3 | 37.13B |